Demographic characteristics of study subjects after PSM ^* . حسب Teng-Li Lin (5559284)

Model vs. WKY group KEGG pathways (Top 15). حسب Xiao Zhang (152326)

"…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …"

Behavioral data. حسب Xiao Zhang (152326)

"…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …"

OPLS-DA model parameter. حسب Xiao Zhang (152326)

"…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …"

Model vs. SHR group KEGG pathways (Top 15). حسب Xiao Zhang (152326)

"…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …"

Network pharmacology analysis predicted the targets of NS on atherosclerosis. حسب Yihua Wang (491766)

Primers used for RT-qPCR. حسب Yihua Wang (491766)

"…The results indicated that NS combination promoted autophagy by inhibiting the PI3K/Akt/mTOR pathway. This significantly alleviated inflammation, reduced apoptosis, and decreasing lipid accumulation, thereby improving the pathological progression of atherosclerosis. …"

Study areas of sample collection in Ethiopia, eastern Africa حسب Amete Mihret Teshale (12072758)

Quantitative Proteomics Unveils the Synergistic Effects of Combination Drugs on Cytoskeleton Composition and Autophagy-Mediated Cell Death in Neuroblastoma حسب Pei-Chen Yu (1860772)

"…Gene set enrichment analysis and Database for Annotation, Visualization, and Integrated Discovery revealed that combination therapy significantly decreased cytoskeleton formation compared with monotherapy, reflecting dramatic reduction in cell migration. …"

PeMSD8. حسب Yuanming Ding (12842858)

Selection of soil particle sampling points. حسب Xueting Ma (390540)

Static analysis results. حسب Xueting Ma (390540)

The disease burden of AA caused by hypertension in 204 countries and regions. حسب Guanghui Yu (423945)

Mode shapes of the first six modes. حسب Xueting Ma (390540)

Mouldboard plough body working resistance response surface. حسب Xueting Ma (390540)

Soil disturbance response surface curved surface. حسب Xueting Ma (390540)

Forest plot depicting hazard ratios for the development of cardiovascular diseases. حسب Teng-Li Lin (5559284)

Time trend of ASDR and ASMR for hypertension -related AA by sex globally and acorss diverse SDI region from 1990 to 2021. حسب Guanghui Yu (423945)

Positive stool samples by pathogen and study sites. حسب Amete Mihret Teshale (12072758)

Socio-demographic and clinical characteristics of participants by study site. حسب Amete Mihret Teshale (12072758)